Teresa Gisinger on Sex Hormones and Cardiovascular Risk in Type 2 DM
Teresa Gisinger, Researcher (Doctoral Candidate) at Medical University of Vienna, shared on LinkedIn:
”I’m excited to share our newly published study
We found that in older men with type 2 diabetes, baseline testosterone and changes in estradiol and SHBG after lifestyle intervention are associated with long-term cardiovascular risk, whereas no comparable link was found in postmenopausal women”
Read the full article here.
Article: Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the LookAHEAD Trial
Authors: Teresa Gisinger, Jiahuan Helen He, Chigolum P. Oyeka, Jianqiao Ma, Nityasree Srialluri, Mark Woodward, Erin D. Michos, Rita R. Kalyani, Jeanne M. Clark, Alexandra Kautzky-Willer, Dhananjay Vaidya, Wendy L. Bennett
Stay updated on all scientific advances with Hemostasis Today.
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress
-
May 5, 2026, 16:17Hannah Omunakwe: Your Sick Child Has a Clot. Did You See That Coming?